Clinical trial for Dyslipidemia
Official title Prescription of Step Counts for Targeted Changes in Body Composition and Cardiometabolic Risk in Overweight/Obese Adults
ClinicalTrials.gov ID: NCT07221279
What this study is testing
- What it's testing
- The study aims to find the right number of daily steps needed to help people lose body fat and lower risks for heart disease and diabetes.
- Who it's for
- Men and women aged 20 to 80 or older who are overweight or obese.
- What's involved
- Participants will wear a step counter and follow a personalized daily step goal while eating normally without diet restrictions.
- Time commitment
- The study lasts eight months and requires regular check-ins to track progress.
- Time commitment: about 8 months
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 and older. Healthy volunteers may be eligible.
You may be able to join if
- ages of 20 years and older
- otherwise healthy adults on prescription medication to treat hypertension or osteoarthritic conditions are eligible to participate
- sedentary people, or people who report engaging in regular walking (no regular structured exercise for at least the past six months)
- relatively stable weight over the previous 6 months (less than 5% fluctuation in body weight)
You likely can't join if
- any diagnosed cardiovascular, metabolic, renal, or pulmonary disease, or any diagnosed cognitive dysfunction
- women who are pregnant or plan on becoming pregnant
- people taking prescription medication to regulate plasma glucose, or that affect metabolism (e.g., thyroid medication)
- people who have undergone an increase or decrease in body weight of ≥ 5% over the previous six months
- current smokers
- people who have engaged in a program of structured exercise other than walking (e.g., weight training, jogging, swimming, cycling) within that last...
See the full eligibility criteria
- ages of 20 years and older
- otherwise healthy adults on prescription medication to treat hypertension or osteoarthritic conditions are eligible to participate
- sedentary people, or people who report engaging in regular walking (no regular structured exercise for at least the past six months)
- relatively stable weight over the previous 6 months (less than 5% fluctuation in body weight)
- any diagnosed cardiovascular, metabolic, renal, or pulmonary disease, or any diagnosed cognitive dysfunction
- women who are pregnant or plan on becoming pregnant
- people taking prescription medication to regulate plasma glucose, or that affect metabolism (e.g., thyroid medication)
- people who have undergone an increase or decrease in body weight of ≥ 5% over the previous six months
- current smokers
- people who have engaged in a program of structured exercise other than walking (e.g., weight training, jogging, swimming, cycling) within that last six months
- older adults (60-plus years old) who score \> 4 on the Short Blessed Test for geriatric cognitive impairment during the first lab visit will be ineligible to participate
The study team makes the final eligibility decision.
Where it is enrolling
- Kennesaw, Georgia, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The study runs about 8 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 20 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Kennesaw, Georgia, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.